Pharmaceutical & Healthcare Seminar – Data Privacy/GDPR | Regulation of Biosimilars | M&A
May Baker McKenzie, Vasagatan 7, Stockholm
11 May 02:30 - 17:00
Legal and Regulatory Challenges Confronting the Industry
Data Privacy/GDPR Compliance in the Healthcare Sector | Cross-border Pharma M&A: successful navigation of key issues | Development and Regulation of Biosimilars
Pharmaceuticals and Healthcare companies face unprecedented challenges in the ever-changing, regulatory, compliance and business landscape. Baker McKenzie’s upcoming seminar will address some of the most significant issues that companies need to respond to in 2017 and beyond, with a particular focus on how these are impacting the role of the in-house legal team.
Our team of specialists will address each topic in the context of the Swedish and wider Nordic market. We have also leveraged the cross border expertise offered by Baker McKenzie’s European Healthcare group to be able to provide an EU perspective on key issues.
Our guest speaker from Trice will talk about difficulties in navigating the complex legislative landscape of Data Privacy when legislators don’t keep abreast with the development of new technologies.
Registration and coffee
Data Privacy/GDPR Compliance in the Healthcare Sector
Michelle Bawn, Baker McKenzie, London, Florian Tannen, Baker McKenzie, Munich and Peder Oxhammar, Baker McKenzie, Stockholm
Data Privacy – Lessons from The Trenches – Trice Imaging
Tomas Hagenfeldt, CFO, Trice Imaging
Cross-border Pharma M&A: successful navigation of key issues
Maria Boccardo, Baker McKenzie, London and Thorsten Seidel, Baker McKenzie, Berlin
Development and Regulation of Biosimilars
Els Janssens, Baker McKenzie, Abu Dhabi and Julie Yeni, Baker McKenzie, Paris